The narrow therapeutic index of oncology drugs makes understanding drug interactions critical for the safe and effective treatment of cancer patients. Small changes in the pharmacodynamics or pharmacokinetics of the drug can decrease efficacy or increase toxicity of the cancer drug potentially causing harm to patients during treatment.